Cigna raises annual profit forecast on strength in specialty drug unit
Cigna raises annual profit forecast on strength in specialty drug unit Reuters
Covered in this story
What has happened since
- Cigna is up 6.6% since this was published, 82 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Cigna
- UBS: $268 → $400 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cigna →Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.